Alembic Pharmaceuticals Limited has announced the successful commissioning of its new state-of-the-art manufacturing facility for pharmaceutical formulations in Pithampur, District Dhar, Madhya Pradesh. The facility has become operational effective today, as per the company’s regulatory filing to the stock exchanges under Regulation 30 of SEBI’s LODR Regulations, 2015.
Strategic Expansion to Boost In-House Manufacturing
The new plant marks a significant expansion in Alembic’s formulation manufacturing capabilities, as the company looks to shift a portion of its third-party production to in-house operations. The move is expected to enhance efficiency, improve quality control, and optimize supply chain operations.
Key Highlights:
- Location: Pithampur, District Dhar, Madhya Pradesh – 454774
- Investment: Approximately ₹205 crore
- Funding Source: Internal accruals and borrowings
- Purpose: Expansion of formulation manufacturing capacity
- Status: Fully commissioned and operational as of today
Alembic Pharmaceuticals currently operates multiple formulation facilities, most of which are already operating at optimal utilization levels. The new plant will not only support the growing domestic and export demand but also allow the company to consolidate its manufacturing footprint by bringing more products under direct production.